drugset / Trial / NCT03676205

Platelet-Rich Plasma in Acute Muscle Injuries

NCT03676205

Phase 2 Completed 41 enrolled University of the Basque Country (UPV/EHU)
RandomizedParallel-groupDouble-blindTreatment

Summary

OBJECTIVE: To evaluate the effect of Platelet Rich Plasma (PRP) injection in muscle injuries. The investigators check football players in the acute phase of hamstrings or quadriceps injuries. Efficacy and safety are evaluated. There are two intramuscular infiltration of PRP (Ortho pras ® system) or a homeopathic product (Traumeel ®) in each of the football players. The number of days between the date of injury and the return to play, the pain, the recurrence and the adverse reactions are registered.

Timeline

Start
2016-10-03
Primary completion
2019-04-08
Completion
2020-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 6 ml Intramuscular
Subject Platelet Rich Plasma Other / unclassified 7 ml Intramuscular

Indications

No indication recorded.